Mutagenic potential of peripheral blood leukocytes: In vivo exposure to the carcinogen 7,12-dimethylbenz[a]anthracene, and the tumor promoter 12-O-tetradecanoylphorbol acetate followed by in vitro co-culture with AS52 cells

Cancer Letters

Volumn 106, Issue 1, 1996, Pages 9-16

  Ariza, Maria E ^a   Oberyszyn, Andrew S ^a   Robertson, Fredika M ^a,b   Williams, Marshall V ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

AS52 cell line; Chemoprevention; Leukocytes; Mutagenesis

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; ACETONE; ANTIOXIDANT; CARCINOGEN; EPIGALLOCATECHIN GALLATE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR PROMOTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; LEUKOCYTE; MOUSE; MUTAGENESIS; MUTATION RATE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MAMMALIA;

EID: 0030598976     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04290-5     Document Type: Article

References (50)

1. [1] Halliwell, B. and Gutteridge, J.M.C. (1990) The role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol., 186, 1-68.
2. [2] Cross, C.E., Halliwell, B., Borish, E.T., Pryor, W.A., Ames, B.N., Saul, R.L., McCord J.M. and Harman, D. (1987) Oxygen radicals and human disease. Ann. Intern. Med., 107. 526-545.
3. [3] Ames, B.N. and Shigenaga, M.K. (1994) Oxidants are a major contributor to cancer and aging. In: Aging, Sex and DNA Repair, pp. 1-14. Editors: C. Bernstein and H. Bernstein. Academic Press, New York.
4. [4] Hopper, C. (1989) Free radicals: research on biochemical bad boys comes of age. J. NIH Res., 1, 101-106.
5. [5] Babior, B.M. (1984) Oxidants from phagocytes: agents of defense and destruction. Blood, 64, 959-966.
6. [6] Fantone, J.C. and Ward, P.A. (1982) Role of oxygen-derived free radicals and metabolites in leukocyte dependent reactions. Am. J. Pathol., 107, 397-418.
7. [7] Repine, J.E., White, J.G., Clawson, C.L. and Holmes, B.M. (1974) The influence of phorbol myristate acetate on the oxygen consumption of polymorphonuclear leukocytes. J. Lab. Clin. Med., 83, 911-920.
8. [8] DeChatelet, L.R., Shirley, P.S. and Johnson, Jr., R.B. (1976) Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood, 47, 545-554.
9. [9] Goldstein, B.D., Witz, G. Amoruso, M., Stone, D.S. and Troll, W. (1981) Stimulation of human polymorphonuclear leukocyte superoxide anion radical production by tumor promoters. Cancer Lett., 11, 257-262.
10. [10] Lewis, J.G. and Adams, D.O. (1985) Induction of 5,6-ring saturated thymine bases in NIH-3T3 cells by phorbol esterstimulated macrophages: role of reactive oxygen intermediates. Cancer Res., 45, 1270-1275.
11. [11] Frenkel, K., Chrzan, K., Troll, W., Teebor, G.W. and Steinberg, J.J. (1986) Radiation-like modification of bases in DNA exposed to tumor promoter-activated polymorphonuclear leukocytes. Cancer Res., 46, 5533-5540.
12. [12] Frenkel, K. and Chrzan, K. (1987) Hydrogen peroxide formation and DNA modification by tumor promoter-activated polymorphonuclear leukocytes. Carcinogenesis, 8, 455-460.
13. 2 formation by activated human polymorphonuclear leukocytes (PMNs). In: Anticarcinogenesis and Radiation Protection, pp. 97-102. Editors: P.A. Cerutti, O.F. Nygaard and M.G. Simic. Plenum Press, New York.
14. [14] Frenkel, K. (1989) Oxidation of DNA bases by tumor promoter-activated processes. Environ. Health Perspect., 81, 45-54.
15. [15] Birnboim, H.C. (1982) DNA strand breakage in leukocytes exposed to tumor promoter, phorbol myristate acetate. Science, 215, 1247-1249.
16. [16] Shacter, E., Beecham, E.J., Covey, J.M., Kohn, K.W. and Potter, M. (1988) Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis, 9, 2297-2304.
17. [17] Schrautstatter, I., Hyslop, P., Jackson, J.H. and Cochrane, C.G. (1988) Oxidant-induced DNA damage of target cells. J. Clin. Invest., 82, 1040-1050.
18. [18] Emerit, I. and Cerutti, P. (1981) Tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate induces chromosomal damage via indirect action. Nature, 293, 144-146.
19. [19] Cerutti, P.A., Amstad, P. and Emerit, I. (1983) Tumor promoter phorbol ester-myristate-acetate induces membrane mediated chromosomal damage. In: Radioprotectors and Anticarcinogens, pp. 527-538. Editors: O.F. Nygaard and M.B. Simic. Academic Press, New York.
20. [20] Dzarilieva, R. and Fusening, N. (1982) Tumor promoter 12-O-tetradecanoyl-phorbol-13-acetate enhances sister chromatid exchanges and numerical and structural chromosomal aberrations in primary mouse epidermal culture. Cancer Lett., 16, 7-17.
21. [21] Philips, B.J., James, T.E.B. and Anderson, D. (1984) Genetic damage in CHO cells exposed to enzymatically generated active oxygen species. Mutat. Res., 126, 265-271.
22. [22] Weitberg, A.B., Weitzman, S.A., Destrempes, M., Latt, S.A. and Stossel, T.P. (1983) Stimulated human phagocytes produce cytogenic changes in cultured mammalian cells. N. Engl. J. Med., 308, 26-30.
23. [23] Weitzman, S.A. and Stossel, T.P. (1981) Mutation caused by human phagocytes. Science, 212, 546-547.
24. [24] Weitzman, S.A. and Stossel, T.P. (1984) Phagocyte-induced mutation in Chinese hamster ovary cells. Cancer Lett., 22, 337-341.
25. [25] Weitzman, S.A., Weitberg, A.B., Clark, E.P. and Stossel, T.P. (1985) Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science, 227, 1231-1233.
26. [26] Trush, M.A., Seed, J.L. and Kensler, T.W. (1985) Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes: possible link between inflammation and cancer. Proc. Natl. Acad. Sci. USA, 82, 5194-5198.
27. [27] Frenkel, K. (1992) Carcinogen-mediated oxidant formation and oxidative DNA damage. Pharmacol. Ther., 53, 127-166.
28. [28] Frenkel, K., Wei, L. and Wei, H. (1995) 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Rad. Biol. Med., 19, 373-380.
29. [29] Troll, W., Witz, G., Goldstein, B., Stone, D. and Sugimura, T. (1982) The role of free oxygen radicals in tumor promotion and carcinogenesis. In: Carcinogenesis, Vol. 7, pp. 593-597. Editors: E. Hecker, W. Kunz, N.E. Fusening, F. Marks and H.W. Thielmann. Raven Press, New York.
30. [30] Nakamura, Y., Colburn, N.H. and Gindhart, T.D. (1985) Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis, 6, 229-235.
31. [31] Weitzman, S.A. and Gordon, L.I. (1990) Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis. Blood, 76, 655-663.
32. [32] Frenkel, K. and Gleichauf, C. (1991) Hydrogen peroxide formation by cells treated with a tumor promoter. Free Rad. Res. Commun., 12-13, 783-794.
33. [33] Boutwell, R.K. (1964) Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res., 4, 207-250.
34. [34] Slaga, T.J., Fisher, S.M., Weeks, C.E., Nelson, K., Mamrack, M. and Klein-Szanto, A.J.P. (1982) Specificity and mechanisms of promoter inhibitors in multistage promotion. In: Carcinogenesis: a Comprehensive Survey, Vol. 7, pp. 19-34. Editors: E. Heckler, N.E. Fusenig, W. Kunz, F. Marks and H.W. Theilmann. Raven Press, New York.
35. [35] Wei, L., Wei, H. and Frenkel, K. (1993) Sensitivity to tumor promotion of SENCAR and C57BL/6J mice correlates with oxidative DNA damage. Carcinogenesis, 14, 841-847.
36. [36] Lewis, J.G. and Adams, D.O. (1987) Early inflammatory changes in the skin of SENCAR and C57BL/6J mice following exposure to 12-O-tetradecanoyl-phorbol-13 acetate. Carcinogenesis, 8, 889-898.
37. [37] Sirak, A.A., Beavis, A.J. and Robertson, F.M. (1991) Enhanced hydroperoxide production by peripheral blood leukocytes following exposure of murine epidermis to 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis, 12, 91-95.
38. [38] Lewis, J.G. and Adams, D.O. (1986) Enhanced release of hydrogen peroxide and metabolites of arachidonic acid by macrophages from SENCAR mice following stimulation with phorbol esters. Cancer Res., 46, 5696-5700.
39. [39] Fisher, S.M., Baldwin, J.K. and Adams, L.M. (1986) Effects of anti-promoters and strain of mouse on tumor-induced oxidants in murine epidermal cells. Carcinogenesis, 7, 915-918.
40. [40] Robertson, F.M., Beavis, A.J., Oberyszyn, T.M., O'Connell, S.M., Dokidos, A., Laskin, D.L., Laskin, J.D. and Reiners, Jr., J.J. (1990) Production of hydrogen peroxide by murine epidermal keratinocytes following treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res., 50, 6062-6067.
41. [41] Mukhtar, H., Wang, Z.Y., Katiyar, S.K. and Agarwal, R. (1992) Tea components: antimutagenic and anticarcinogenic effects. Prev. Med., 21, 351-360.
42. [42] Huang, M.-T., Ho, C.-T., Wang, Z.Y., Ferraro, T., Fennegan-Olive, T., Lou, Y.-R., Mitchell, J.M., Laskin, J.D., Newmark, H., Yang, C.S. and Conney, A.H. (1992) Inhibitory effect of topical application of a green tea polyphenol fraction on tumor initiation and promotion in mouse skin. Carcinogenesis, 13, 947-954.
43. [43] Wang, E.Y., Haung, M.-T., Lou, Y.-R., Xie, J.G., Reuhl, K.R., Newmark, H.L., Ho, C.-T., Yang, C.S. and Conney, A.H. (1994) Inhibitory effects of black tea, green tea, decaffeinated black tea and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz[a]anthracene-initiated SKH-1 mice. Cancer Res., 54, 3428-3435.
44. [44] Tindall, K.R. and Stankowski, L.F. (1987) Deletion mutations are associated with the differential induced mutant frequency response of the AS52 and CHO-K1-BH4 cell lines. In: Banbury Report 28: Mammalian Cell Mutagenesis, pp. 283-292. Editors: M. Moore, D. DeMarini, F. deSerres and K. Tindall. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
45. [45] Tindall, K.R. and Stankowski, L.F. (1987) Characterization of the AS52 cell line for use in mammalian cell mutagenesis studies. In: Banbury Report 28: Mammalian Cell Mutagenesis, pp. 71-79. Editors: M. Moore, D. DeMarini, F. deSerres and K. Tindall. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
46. [46] Tindall, K.R., Stankowski, L.F., Machanoff, R. and Hsie, A.W. (1987) Detection of deletion mutations in pSV2gpt transformed cells. Mol. Cell. Biol., 4, 1411-1415.
47. [47] Hsie, A.W., Recio, L., Katz, S., Lee, C.Q., Wagner, M. and Schenley, R.L. (1986) Evidence for reactive oxygen species inducing mutations in mammalian cells. Proc. Natl. Acad. Sci. USA, 83, 9616-9620.
48. [48] An, J. and Hsie, A.W. (1994) Polymerase chain reaction-directed DNA sequencing of bleomycin-induced 'non-deletion'-type 6-thioguanine-resistant mutants in Chinese hamster ovary cell derivative AS52. Environ. Mol. Mutagen., 23, 101-109.
49. [49] Fox, J.G., Cohen, B. and Loew, F.M. (Editors) (1984) Techniques of Experimentation in Laboratory Animal Medicine, pp. 563-594. Academic Press, Orlando, FL.
50. [50] Ariza, M.E. and Williams, M.V. (1996) Mutagenesis of AS52 cells by low concentrations of lead (II) and mercury (II). Environ. Mol. Mutagen., 27, 30-33.